Clinical Trial Update: Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and midazolam interaction of a Pfizer investigational compound in healthy overweight/obese adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Metabolism Disorders
• Type 2 Diabetes Mellitus

Drugs mentioned

• Midazolam (Midazolam)
• Pfizer investigational drug

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED